IBDEI1EJ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22673,0)
;;=L92.1^^76^975^4
;;^UTILITY(U,$J,358.3,22673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22673,1,3,0)
;;=3^Necrobiosis Lipoidica NEC
;;^UTILITY(U,$J,358.3,22673,1,4,0)
;;=4^L92.1
;;^UTILITY(U,$J,358.3,22673,2)
;;=^5009462
;;^UTILITY(U,$J,358.3,22674,0)
;;=L20.81^^76^975^8
;;^UTILITY(U,$J,358.3,22674,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22674,1,3,0)
;;=3^Neurodermatitis,Atopic
;;^UTILITY(U,$J,358.3,22674,1,4,0)
;;=4^L20.81
;;^UTILITY(U,$J,358.3,22674,2)
;;=^5009108
;;^UTILITY(U,$J,358.3,22675,0)
;;=D48.5^^76^975^7
;;^UTILITY(U,$J,358.3,22675,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22675,1,3,0)
;;=3^Neoplasm,Skin,Uncertain Behavior
;;^UTILITY(U,$J,358.3,22675,1,4,0)
;;=4^D48.5
;;^UTILITY(U,$J,358.3,22675,2)
;;=^267777
;;^UTILITY(U,$J,358.3,22676,0)
;;=D49.2^^76^975^6
;;^UTILITY(U,$J,358.3,22676,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22676,1,3,0)
;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
;;^UTILITY(U,$J,358.3,22676,1,4,0)
;;=4^D49.2
;;^UTILITY(U,$J,358.3,22676,2)
;;=^5002272
;;^UTILITY(U,$J,358.3,22677,0)
;;=L60.0^^76^975^3
;;^UTILITY(U,$J,358.3,22677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22677,1,3,0)
;;=3^Nail,Ingrowing
;;^UTILITY(U,$J,358.3,22677,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,22677,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,22678,0)
;;=L60.9^^76^975^1
;;^UTILITY(U,$J,358.3,22678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22678,1,3,0)
;;=3^Nail Disorder,Unspec
;;^UTILITY(U,$J,358.3,22678,1,4,0)
;;=4^L60.9
;;^UTILITY(U,$J,358.3,22678,2)
;;=^5009240
;;^UTILITY(U,$J,358.3,22679,0)
;;=Z91.19^^76^975^10
;;^UTILITY(U,$J,358.3,22679,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22679,1,3,0)
;;=3^Noncompliance w/ Medical Treatment/Regimen
;;^UTILITY(U,$J,358.3,22679,1,4,0)
;;=4^Z91.19
;;^UTILITY(U,$J,358.3,22679,2)
;;=^5063618
;;^UTILITY(U,$J,358.3,22680,0)
;;=Z23.^^76^975^5
;;^UTILITY(U,$J,358.3,22680,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22680,1,3,0)
;;=3^Need for Immunization(s)
;;^UTILITY(U,$J,358.3,22680,1,4,0)
;;=4^Z23.
;;^UTILITY(U,$J,358.3,22680,2)
;;=^5062795
;;^UTILITY(U,$J,358.3,22681,0)
;;=E80.1^^76^976^21
;;^UTILITY(U,$J,358.3,22681,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22681,1,3,0)
;;=3^Porphyria Cutanea Tarda
;;^UTILITY(U,$J,358.3,22681,1,4,0)
;;=4^E80.1
;;^UTILITY(U,$J,358.3,22681,2)
;;=^5002982
;;^UTILITY(U,$J,358.3,22682,0)
;;=L56.4^^76^976^20
;;^UTILITY(U,$J,358.3,22682,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22682,1,3,0)
;;=3^Polymorphous Light Eruption
;;^UTILITY(U,$J,358.3,22682,1,4,0)
;;=4^L56.4
;;^UTILITY(U,$J,358.3,22682,2)
;;=^5009218
;;^UTILITY(U,$J,358.3,22683,0)
;;=L10.0^^76^976^4
;;^UTILITY(U,$J,358.3,22683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22683,1,3,0)
;;=3^Pemphigus Vulgaris
;;^UTILITY(U,$J,358.3,22683,1,4,0)
;;=4^L10.0
;;^UTILITY(U,$J,358.3,22683,2)
;;=^91129
;;^UTILITY(U,$J,358.3,22684,0)
;;=L41.3^^76^976^2
;;^UTILITY(U,$J,358.3,22684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22684,1,3,0)
;;=3^Parapsoriasis,Small Plague
;;^UTILITY(U,$J,358.3,22684,1,4,0)
;;=4^L41.3
;;^UTILITY(U,$J,358.3,22684,2)
;;=^5009173
;;^UTILITY(U,$J,358.3,22685,0)
;;=L41.4^^76^976^1
;;^UTILITY(U,$J,358.3,22685,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22685,1,3,0)
;;=3^Parapsoriasis,Large Plague
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1EJ 3756 printed Apr 09, 2024@21:28:35 Page 2
IBDEI1EJ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22673,0)
+2 ;;=L92.1^^76^975^4
+3 ;;^UTILITY(U,$J,358.3,22673,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,22673,1,3,0)
+6 ;;=3^Necrobiosis Lipoidica NEC
+7 ;;^UTILITY(U,$J,358.3,22673,1,4,0)
+8 ;;=4^L92.1
+9 ;;^UTILITY(U,$J,358.3,22673,2)
+10 ;;=^5009462
+11 ;;^UTILITY(U,$J,358.3,22674,0)
+12 ;;=L20.81^^76^975^8
+13 ;;^UTILITY(U,$J,358.3,22674,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,22674,1,3,0)
+16 ;;=3^Neurodermatitis,Atopic
+17 ;;^UTILITY(U,$J,358.3,22674,1,4,0)
+18 ;;=4^L20.81
+19 ;;^UTILITY(U,$J,358.3,22674,2)
+20 ;;=^5009108
+21 ;;^UTILITY(U,$J,358.3,22675,0)
+22 ;;=D48.5^^76^975^7
+23 ;;^UTILITY(U,$J,358.3,22675,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,22675,1,3,0)
+26 ;;=3^Neoplasm,Skin,Uncertain Behavior
+27 ;;^UTILITY(U,$J,358.3,22675,1,4,0)
+28 ;;=4^D48.5
+29 ;;^UTILITY(U,$J,358.3,22675,2)
+30 ;;=^267777
+31 ;;^UTILITY(U,$J,358.3,22676,0)
+32 ;;=D49.2^^76^975^6
+33 ;;^UTILITY(U,$J,358.3,22676,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,22676,1,3,0)
+36 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
+37 ;;^UTILITY(U,$J,358.3,22676,1,4,0)
+38 ;;=4^D49.2
+39 ;;^UTILITY(U,$J,358.3,22676,2)
+40 ;;=^5002272
+41 ;;^UTILITY(U,$J,358.3,22677,0)
+42 ;;=L60.0^^76^975^3
+43 ;;^UTILITY(U,$J,358.3,22677,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,22677,1,3,0)
+46 ;;=3^Nail,Ingrowing
+47 ;;^UTILITY(U,$J,358.3,22677,1,4,0)
+48 ;;=4^L60.0
+49 ;;^UTILITY(U,$J,358.3,22677,2)
+50 ;;=^5009234
+51 ;;^UTILITY(U,$J,358.3,22678,0)
+52 ;;=L60.9^^76^975^1
+53 ;;^UTILITY(U,$J,358.3,22678,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,22678,1,3,0)
+56 ;;=3^Nail Disorder,Unspec
+57 ;;^UTILITY(U,$J,358.3,22678,1,4,0)
+58 ;;=4^L60.9
+59 ;;^UTILITY(U,$J,358.3,22678,2)
+60 ;;=^5009240
+61 ;;^UTILITY(U,$J,358.3,22679,0)
+62 ;;=Z91.19^^76^975^10
+63 ;;^UTILITY(U,$J,358.3,22679,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,22679,1,3,0)
+66 ;;=3^Noncompliance w/ Medical Treatment/Regimen
+67 ;;^UTILITY(U,$J,358.3,22679,1,4,0)
+68 ;;=4^Z91.19
+69 ;;^UTILITY(U,$J,358.3,22679,2)
+70 ;;=^5063618
+71 ;;^UTILITY(U,$J,358.3,22680,0)
+72 ;;=Z23.^^76^975^5
+73 ;;^UTILITY(U,$J,358.3,22680,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,22680,1,3,0)
+76 ;;=3^Need for Immunization(s)
+77 ;;^UTILITY(U,$J,358.3,22680,1,4,0)
+78 ;;=4^Z23.
+79 ;;^UTILITY(U,$J,358.3,22680,2)
+80 ;;=^5062795
+81 ;;^UTILITY(U,$J,358.3,22681,0)
+82 ;;=E80.1^^76^976^21
+83 ;;^UTILITY(U,$J,358.3,22681,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,22681,1,3,0)
+86 ;;=3^Porphyria Cutanea Tarda
+87 ;;^UTILITY(U,$J,358.3,22681,1,4,0)
+88 ;;=4^E80.1
+89 ;;^UTILITY(U,$J,358.3,22681,2)
+90 ;;=^5002982
+91 ;;^UTILITY(U,$J,358.3,22682,0)
+92 ;;=L56.4^^76^976^20
+93 ;;^UTILITY(U,$J,358.3,22682,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,22682,1,3,0)
+96 ;;=3^Polymorphous Light Eruption
+97 ;;^UTILITY(U,$J,358.3,22682,1,4,0)
+98 ;;=4^L56.4
+99 ;;^UTILITY(U,$J,358.3,22682,2)
+100 ;;=^5009218
+101 ;;^UTILITY(U,$J,358.3,22683,0)
+102 ;;=L10.0^^76^976^4
+103 ;;^UTILITY(U,$J,358.3,22683,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,22683,1,3,0)
+106 ;;=3^Pemphigus Vulgaris
+107 ;;^UTILITY(U,$J,358.3,22683,1,4,0)
+108 ;;=4^L10.0
+109 ;;^UTILITY(U,$J,358.3,22683,2)
+110 ;;=^91129
+111 ;;^UTILITY(U,$J,358.3,22684,0)
+112 ;;=L41.3^^76^976^2
+113 ;;^UTILITY(U,$J,358.3,22684,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,22684,1,3,0)
+116 ;;=3^Parapsoriasis,Small Plague
+117 ;;^UTILITY(U,$J,358.3,22684,1,4,0)
+118 ;;=4^L41.3
+119 ;;^UTILITY(U,$J,358.3,22684,2)
+120 ;;=^5009173
+121 ;;^UTILITY(U,$J,358.3,22685,0)
+122 ;;=L41.4^^76^976^1
+123 ;;^UTILITY(U,$J,358.3,22685,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,22685,1,3,0)
+126 ;;=3^Parapsoriasis,Large Plague
